More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy-Reference-Cited by-同舟云学术

More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy

Published:2016-06 Issue:6 Volume:195 Page:1767-1772
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

ElShafei Ahmed¹²,Nyame Yaw¹,Kara Onder¹,Badawy Atef³,Amujiogu Ifeanyi¹,Fareed Khaled¹,Klein Eric¹,Jones J. Stephen¹

Affiliation:

1. Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio

2. Urology Department, Al Kasr Al Aini Hospital, Cairo University, Giza, Egypt

3. Urology Department, Faculty of Medicine, Menofiya University, Menofiya, Egypt

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Active surveillance for prostate cancer: overview and update;Klotz;Curr Treat Options Oncol,2013

2. What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?;Loeb;J Clin Oncol,2011

3. Active surveillance for prostate cancer: a systematic review of the literature;Dall’Era;Eur Urol,2012

4. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico;JAMA,1998

5. NCCN clinical practice guidelines in oncology: prostate cancer early detection;Kawachi;J Natl Compr Canc Netw,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer;JAMA Oncology;2024-06-01

2. Development and Validation of MyProstateScore 2.0 to Detect Clinically Significant Prostate Cancer;2023-04-17

3. MyProstateScore in men considering repeat biopsy: validation of a simple testing approach;Prostate Cancer and Prostatic Diseases;2022-12-30

4. The evolving clinical use of prostate cancer biomarkers;Prostate Cancer and Prostatic Diseases;2022-07-07

5. Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer;World Journal of Urology;2022-03-26